ESSA Pharma Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ESSA Pharma's estimated annual revenue is currently $5.3M per year.(i)
  • ESSA Pharma's estimated revenue per employee is $155,000

Employee Data

  • ESSA Pharma has 34 Employees.(i)
  • ESSA Pharma grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M4018%$40MN/A
#2
$0.2M20%N/AN/A
#3
$1.2M1623%N/AN/A
#4
$2.5M16-20%N/AN/A
#5
$12.2M797%N/AN/A
#6
$1.8M2315%$89.5MN/A
#7
$2.5M160%N/AN/A
#8
$40.3M26021%N/AN/A
#9
$0.9M60%N/AN/A
#10
$0.9M6200%N/AN/A
Add Company

As a clinical-stage pharmaceutical company founded on cutting-edge research, ESSA is focused on developing novel therapeutics for cancer patients. ESSA embraces innovation not only in our products but also in our approach. We're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ESSA Pharma News

2022-04-17 - ESSA Pharma Inc. (NASDAQ:EPIX) Short Interest Update

lifted its holdings in ESSA Pharma by 22.9% during the 4th quarter. Soleus Capital Management L.P. now owns 3,525,457 shares of the company's...

2022-04-06 - Zacks: Brokerages Expect ESSA Pharma Inc. (NASDAQ:EPIX ...

ESSA Pharma reported earnings of ($0.36) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of...

2022-04-06 - ESSA Pharma Announces the Presentation of Preclinical Data ...

About ESSA Pharma Inc. ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.6M340%N/A
#2
$9.8M34-68%$494.1M
#3
$3.9M34N/AN/A
#4
$4.4M34N/AN/A
#5
$3.9M34-6%N/A